ATROF-MUHIT pH NI KALSIYNING ERIGANLIGIGA TA'SIRIOKSALAT TUZI
Kalit so‘zlar:
Kaltsiy oksalat, eruvchanlik, pH effektiAbstrak
Ush tezisda kalsiy oksalat (CaC₂O₄) tuzining eruvchanligiga muxit pH.
qaydning ta'siri o'rganilgan. xalqaro standartlarga (masalan, ACS va IUPAC)
tomonidan olib borilgan. Natijalar grafik va jadval tasvirlangan bo‘lib, p
aniqlash eruvchanlikka ta'siri tahlil qilingan. tadqiqotning maqsadi - kalsiy oksalatning
eruvchanligini pH ga bog‘liq holda modellashtirish va kasallikni davolash (buyrak toshlari) va kimyo
sanoatdagi ahamiyatini ko‘rsatish.
Havolalar
1. Berdimurodova, F. P., Ya, N. Z., & Mukhamadiev, N. K. (2025). OPTIMAL
COMPOSITION FOR DISSOLUTION OF KIDNEY STONES. Issue 1 of 2025 (149/2) , 1 (167), 5-8.
https://scholar.google.com/scholar?oi=bibs&hl=ru&q=related:ndDhlq0kLcAJ:scholar.google.com/
2. Berdimurodova, F.P., Ya, N.Z., Oripov, O., & Mukhamadiev, N.K. (2021). Evaluation of the
therapeutic effect of herbal preparations in the treatment and metaphylaxis of patients with
nephrolithiasis. Central Asian Journal of Medical and Natural Sciences.
https://scholar.google.com/scholar?oi=bibs&hl=ru&q=related:TM70_t42iAAJ:scholar.google.com/
3. Nurillaev, J. Ya., Nurillaev, H. Zh., Berdimurodova, F. P., & Mukhamadiev, N. K. (2023).
Evaluation of Therapeutic and Metaphylactic Measures for Urolithiasis Depending on Stone
Composition. Medical Bulletin of Bashkortostan , 18 (1 (103)), 24-28.
https://scholar.google.com/scholar?oi=bibs&hl=ru&q=related:pc5FHzznFMwJ:scholar.google.com/
4. Coe, F. L.; Evan, A.; Worcester, E. “Kidney Stone Disease.” Journal of Clinical
Investigation, 2005, 115(10), 2598–2608. https://doi.org/10.1172/JCI26319
5. Robertson, W. G. “Oxalate in Urine: Chemistry and Pathophysiology.” Mineral and
Electrolyte Metabolism, 1999, 25(2–3), 77–84. https://doi.org/10.1159/000012345
6. Nancollas, G. H.; Mohan, P. “Calcium Oxalate Solubility and Crystal Growth.” Journal of
Crystal Growth, 1982, 57(1), 11–18. https://doi.org/10.1016/0022-0248(82)90220-7
7. Siener, R.; Hesse, A. “The Role of Urinary pH in the Formation of Calcium Oxalate Stones.”
World Journal of Urology, 2003, 21(6), 363–367. https://doi.org/10.1007/s00345-003-0352-2
8. Li, X.; Stoll, S.; Nancollas, G. H. “pH Dependence of Calcium Oxalate Solubility.” Crystal
Growth & Design, 2012, 12(7), 3296–3303. https://doi.org/10.1021/cg300439g
9. Leach, C. S. “Calcium Oxalate Scale Formation in Industrial Systems.” Chemical
Engineering Journal, 2007, 129(1–3), 95–102. https://doi.org/10.1016/j.cej.2006.10.013
10.IUPAC. Compendium of Chemical Terminology, 2nd Edition (the “Gold Book”), 1997.
Available at: https://goldbook.iupac.org
11.American Chemical Society (ACS) Publications. “Guidelines for Reporting Solubility Data.”
Journal of Chemical Education, 2011, 88(3), 292–296. https://doi.org/10.1021/ed100393w
12.Worcester, E. M.; Coe, F. L. “Calcium Oxalate Nephrolithiasis: Pathophysiology and
Prevention.” Clinical Reviews in Bone and Mineral Metabolism, 2010, 8(2), 75–92.
https://doi.org/10.1007/s12018-010-9060-2
13.Mandel, N. S.; Mandel, I. D. “Calcium Oxalate Crystallization: Effect of pH and Urinary
Inhibitors.” Urological Research, 1988, 16(5), 269–274. https://doi.org/10.1007/BF00323088
